Search - tctmd.com

Displaying 261 - 280 of 340

Sort: Relevancy | Date

Presentation TVT 2022

Severe TR in the Setting of Advanced RV Dysfunction (Case-based)

Presenter: Edwin Ho

June 08, 2022

Presentation TVT 2022

Massive Annular Dilatation: Current Technological Solutions and Limitations

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2022

Massive Annular Dilatation: Implications for Repair Durability and Valve Sizing

Presenter: Robert Smith

June 08, 2022

Presentation TVT 2022

Innovation in TTVI: Ongoing Challenges and Unmet Needs (Case-based)

Presenter: Neil Fam

June 08, 2022

Presentation TVT 2022

Transcatheter Enhancers and Leaflet Extenders: Technology Concepts and Program Updates

Presenter: Howard Song

June 08, 2022

Presentation TVT 2022

Transcatheter Chordal Replacement: Technology Concepts and Program Updates

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2022

You’re All Wrong: A Toolbox Approach Is the Future of Transcatheter Mitral Intervention!

Presenter: Vinod H. Thourani

June 08, 2022

Presentation TVT 2022

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Presenter: Brian Whisenant

June 08, 2022

Presentation TVT 2022

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Presenter: D. Scott Lim

June 08, 2022

Presentation TVT 2022

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Presenter: Scott Lim

June 08, 2022

Presentation TVT 2022

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Presenter: Paul Sorajja

June 08, 2022

Presentation TVT 2022

Innovation in TMVr: Lessons Learned From the Surgeons

Presenter: Thomas Modine

June 08, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EuroPCR 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Yael L. Maxwell

May 27, 2022

News Conference News EAS 2022

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Michael O'Riordan

May 26, 2022

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Shelley Wood

May 26, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

Advertisement

Severe TR in the Setting of Advanced RV Dysfunction (Case-based)

Massive Annular Dilatation: Current Technological Solutions and Limitations

Massive Annular Dilatation: Implications for Repair Durability and Valve Sizing

Innovation in TTVI: Ongoing Challenges and Unmet Needs (Case-based)

Transcatheter Enhancers and Leaflet Extenders: Technology Concepts and Program Updates

Transcatheter Chordal Replacement: Technology Concepts and Program Updates

You’re All Wrong: A Toolbox Approach Is the Future of Transcatheter Mitral Intervention!

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Innovation in TMVr: Lessons Learned From the Surgeons

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content